
GOP Zika Funding Bill Fails in Re-vote as New Epidemiological Data Emerge
Congress failed to reach a decision on Zika funding today as a new study reveals that the epidemic is expected to last well into 2019.
Congress failed to reach a decision on Zika funding today as a new study reveals that the epidemic is expected to last well into 2019.
It’s been several months since President Obama first insisted that Congress take action against the impending Zika threat. In early February, the Obama administration requested $1.9 billion in federal funds to aid in combating active Zika transmission in the United States. The Senate
According to
Congress’ failure to come to a decision on funding comes on the heels of recently revealed information on just how long we could be battling the virus.
According to
Of note is the fact that the herd immunity is “unlikely to be sufficient to prevent ongoing and substantial risk to pregnant women in future Zika epidemics.” If this proves to be true, a vaccine for the virus remains paramount.
Fortunately, the stall on government funding has not stopped research and infection prevention efforts. In the hopes of providing funds for rapid response, the Centers for Disease Control and Prevention (CDC) recently
With three US territories currently experiencing
In a statement, EPA Administrator Gina McCarthy stated, “An integrated and comprehensive approach includes reducing places where mosquitoes lay eggs, keeping them out of houses, and reducing the populations of both larval and adult mosquitoes by treating areas with EPA-approved products.”
Infection with the Zika virus during pregnancy has been confirmed to cause several neurological impairments in fetuses. As a result, both the CDC and the World Health Organization (WHO) have issued travel warnings, recommending that pregnant women, women of childbearing age, or male sexual partners of these women (who can transfer the virus through semen) avoid areas with known active Zika virus transmission, or travel at their own risk.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.